Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription 17.10.2022 2 Arch Virol 1 Biochem Biophys Res Commun 11 BMJ 5 J Infect Dis 3 J Virol 7 JAMA 4 Lancet 3 MMWR Morb Mortal Wkly Rep 5 N Engl J Med 2 Pediatrics 1 PLoS Biol 6 PLoS Comput Biol 46 PLoS One 2 Proc Natl Acad Sci U S A 12 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. GRACHEVA AV, Korchevaya ER, Ammour YI, Smirnova DI, et al
   Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light.
   Arch Virol. 2022;167:2181-2191.
   PubMed         Abstract available
   
   
2. DE OLIVEIRA CM, Romano CM, Sussuchi L, Cota BDCV, et al
   SARS-CoV-2 BA.1 and BA.2 coinfection detected by genomic surveillance in Brazil, January 2022.
   Arch Virol. 2022;167:2271-2273.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

3. MUHAMMAD JS, ElGhazali G, Shafarin J, Mohammad MG, et al
   SARS-CoV-2-induced hypomethylation of the ferritin heavy chain (FTH1) gene underlies serum hyperferritinemia in severe COVID-19 patients.
   Biochem Biophys Res Commun. 2022;631:138-145.
   PubMed         Abstract available
   
   

   
   BMJ

4. WISE J
   Covid-19: Antiviral purchased by UK government does not lower risk of hospital admission, trial shows.
   BMJ. 2022;379:o2441.
   PubMed        
   
   
5. ADAMS K, Rhoads JP, Surie D, Gaglani M, et al
   Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study.
   BMJ. 2022;379:e072065.
   PubMed         Abstract available
   
   
6. AGGARWAL A, Walter FM, Sullivan R, van der Meulen J, et al
   "Shopping around" for treatment is not a solution to cancer backlog.
   BMJ. 2022;379:e071967.
   PubMed        
   
   
7. IACOBUCCI G
   Evusheld: Government is urged to expedite covid antibody treatment for vulnerable patients.
   BMJ. 2022;379:o2431.
   PubMed        
   
   
8. TANNE JH
   US gun deaths increased by 35% during the early covid-19 pandemic.
   BMJ. 2022;379:o2430.
   PubMed        
   
   
9. IACOBUCCI G
   Covid-19: Hospital admissions rise in England as some trusts reinstate mask requirements.
   BMJ. 2022;379:o2440.
   PubMed        
   
   
10. JOLLIFFE DA, Holt H, Greenig M, Talaei M, et al
    Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT).
    BMJ. 2022;378:e071230.
    PubMed         Abstract available
    
    
11. BRUNVOLL SH, Nygaard AB, Ellingjord-Dale M, Holland P, et al
    Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial.
    BMJ. 2022;378:e071245.
    PubMed         Abstract available
    
    
12. DINSDALE P
    Covid-19: Don't let economic crisis distract from preparing for a future pandemic, conference hears.
    BMJ. 2022;379:o2417.
    PubMed        
    
    
13. 
    It's time to redouble and refocus our efforts to fight covid, not retreat.
    BMJ. 2022;379:o2423.
    PubMed        
    
    
14. DHILLON R, Karan A
    Overcoming "failures of imagination"-rethinking the US covid-19 pandemic response.
    BMJ. 2022;379:o2397.
    PubMed        
    
    

    
    J Infect Dis

15. JONES PS, Yeh KW, Brosnan HK, Regos-Stewart D, et al
    Evaluation of the Homeless Management Information System for COVID-19 Surveillance Among People Experiencing Homelessness.
    J Infect Dis. 2022;226.
    PubMed         Abstract available
    
    
16. SHOVER CL, Rosen A, Mata J, Robie B, et al
    Engaging Same-Day Peer Ambassadors to Increase Coronavirus Disease 2019 Vaccination Among People Experiencing Unsheltered Homelessness in Los Angeles County: A Hybrid Feasibility-Evaluation Study.
    J Infect Dis. 2022;226.
    PubMed         Abstract available
    
    
17. GIBSON C, Schumann C, Neuschel K, McBride JA, et al
    COVID-19 Vaccination Coverage Among People Experiencing Homelessness in a Highly Vaccinated Midwest County-Dane County, Wisconsin, 2021.
    J Infect Dis. 2022;226.
    PubMed         Abstract available
    
    
18. ALLEN EM, Smither B, Barranco L, Reynolds J, et al
    Communicating Effectively With People Experiencing Homelessness to Prevent Infectious Diseases.
    J Infect Dis. 2022;226.
    PubMed         Abstract available
    
    
19. CHOW EJ, Casto AM, Roychoudhury P, Han PD, et al
    The Clinical and Genomic Epidemiology of Rhinovirus in Homeless Shelters-King County, Washington.
    J Infect Dis. 2022;226.
    PubMed         Abstract available
    
    

    
    J Virol

20. PENN R, Tregoning JS, Flight KE, Baillon L, et al
    Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model.
    J Virol. 2022 Oct 13:e0117822. doi: 10.1128/jvi.01178.
    PubMed         Abstract available
    
    
21. GELLENONCOURT S, Saunders N, Robinot R, Auguste L, et al
    The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    J Virol. 2022 Sep 19:e0130122. doi: 10.1128/jvi.01301.
    PubMed         Abstract available
    
    
22. VAN ROYEN T, Sedeyn K, Moschonas GD, Toussaint W, et al
    An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25.
    J Virol. 2022;96:e0129722.
    PubMed         Abstract available
    
    

    
    JAMA

23. HSU CK, Lai CC
    Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant.
    JAMA. 2022;328:1460.
    PubMed        
    
    
24. DORABAWILA V, Bassett MT, Rosenberg ES
    Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant-Reply.
    JAMA. 2022;328:1460-1461.
    PubMed        
    
    
25. KUEHN BM
    Lowest US Life Expectancy Since 1996 Linked to COVID-19.
    JAMA. 2022;328:1389.
    PubMed        
    
    
26. KELLY JD, Leonard S, Hoggatt KJ, Boscardin WJ, et al
    Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
    JAMA. 2022 Sep 26. pii: 2796892. doi: 10.1001/jama.2022.17985.
    PubMed         Abstract available
    
    
27. TENFORDE MW, Link-Gelles R, Patel MM
    Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
    JAMA. 2022 Sep 26. pii: 2796894. doi: 10.1001/jama.2022.14660.
    PubMed        
    
    
28. LIN DY, Gu Y, Xu Y, Wheeler B, et al
    Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
    JAMA. 2022 Sep 26. pii: 2796893. doi: 10.1001/jama.2022.17876.
    PubMed         Abstract available
    
    
29. WEBBER C, Myran DT, Milani C, Turcotte L, et al
    Cognitive Decline in Long-term Care Residents Before and During the COVID-19 Pandemic in Ontario, Canada.
    JAMA. 2022 Sep 12. pii: 2796449. doi: 10.1001/jama.2022.17214.
    PubMed        
    
    

    
    Lancet

30. WONG CKH, Au ICH, Lau KTK, Lau EHY, et al
    Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kon
    Lancet. 2022;400:1213-1222.
    PubMed         Abstract available
    
    
31. BURDET C, Ader F
    Real-world effectiveness of oral antivirals for COVID-19.
    Lancet. 2022;400:1175-1176.
    PubMed        
    
    
32. THE LANCET
    COVID-19: the case for prosociality.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01761.
    PubMed        
    
    
33. SACHS JD, Karim SSA, Aknin L, Allen J, et al
    The Lancet Commission on lessons for the future from the COVID-19 pandemic.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01585.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

34. MA KC, Winn A, Moline HL, Scobie HM, et al
    Increase in Acute Respiratory Illnesses Among Children and Adolescents Associated with Rhinoviruses and Enteroviruses, Including Enterovirus D68 - United States, July-September 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1265-1270.
    PubMed         Abstract available
    
    
35. PEREZ A, Lively JY, Curns A, Weinberg GA, et al
    Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:1253-1259.
    PubMed         Abstract available
    
    
36. COLLINS JP, Shah HJ, Weller DL, Ray LC, et al
    Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:1260-1264.
    PubMed         Abstract available
    
    

    
    N Engl J Med

37. TAKASHITA E, Yamayoshi S, Fukushi S, Suzuki T, et al
    Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75.
    N Engl J Med. 2022;387:1236-1238.
    PubMed        
    
    
38. CHALKIAS S, Harper C, Vrbicky K, Walsh SR, et al
    A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
    N Engl J Med. 2022 Sep 16. doi: 10.1056/NEJMoa2208343.
    PubMed         Abstract available
    
    
39. HAVERVALL S, Marking U, Svensson J, Greilert-Norin N, et al
    Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2209651.
    PubMed        
    
    
40. COLLIE S, Nayager J, Bamford L, Bekker LG, et al
    Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210093.
    PubMed        
    
    
41. QU P, Faraone JN, Evans JP, Zheng YM, et al
    Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2210546.
    PubMed        
    
    

    
    Pediatrics

42. ESSINK BJ, Heeringa M, Jeanfreau RJ, Finn D, et al
    Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial.
    Pediatrics. 2022 Oct 10. pii: 189691. doi: 10.1542/peds.2022-057509.
    PubMed         Abstract available
    
    
43. NAYAK JL, Caserta MT
    Cell-Culture-Based Influenza Vaccines: Don't Put All of Your Influenza Vaccines in the Egg Basket.
    Pediatrics. 2022 Oct 10. pii: 189690. doi: 10.1542/peds.2022-058143.
    PubMed        
    
    

    
    PLoS Biol

44. DAY T, Kennedy DA, Read AF, Gandon S, et al
    Pathogen evolution during vaccination campaigns.
    PLoS Biol. 2022;20:e3001804.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

45. LIN Y, Loo L, Tran A, Lin DM, et al
    Scalable workflow for characterization of cell-cell communication in COVID-19 patients.
    PLoS Comput Biol. 2022;18:e1010495.
    PubMed         Abstract available
    
    
46. KREFL D, Bergmann S
    Cross-GWAS coherence test at the gene and pathway level.
    PLoS Comput Biol. 2022;18:e1010517.
    PubMed         Abstract available
    
    
47. WANG E, Chakraborty AK
    Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants.
    PLoS Comput Biol. 2022;18:e1010563.
    PubMed         Abstract available
    
    
48. MCANDREW T, Reich NG
    An expert judgment model to predict early stages of the COVID-19 pandemic in the United States.
    PLoS Comput Biol. 2022;18:e1010485.
    PubMed         Abstract available
    
    
49. ZHANG L, Chen L, Yu XA, Duvallet C, et al
    MicrobiomeCensus estimates human population sizes from wastewater samples based on inter-individual variability in gut microbiomes.
    PLoS Comput Biol. 2022;18:e1010472.
    PubMed         Abstract available
    
    
50. BOSSE NI, Abbott S, Bracher J, Hain H, et al
    Comparing human and model-based forecasts of COVID-19 in Germany and Poland.
    PLoS Comput Biol. 2022;18:e1010405.
    PubMed         Abstract available
    
    

    
    PLoS One

51. HACKNEY A, Yung M, Somasundram KG, Nowrouzi-Kia B, et al
    Working in the digital economy: A systematic review of the impact of work from home arrangements on personal and organizational performance and productivity.
    PLoS One. 2022;17:e0274728.
    PubMed         Abstract available
    
    
52. HANDAYANI S, Rias YA, Kurniasari MD, Agustin R, et al
    Relationship of spirituality, health engagement, health belief and attitudes toward acceptance and willingness to pay for a COVID-19 vaccine.
    PLoS One. 2022;17:e0274972.
    PubMed         Abstract available
    
    
53. PETROVIC V, Ristic M, Milosavljevic B, Djilas M, et al
    Pneumococcal carriage in adults aged 50 years and older in outpatient health care facility during pandemic COVID-19 in Novi Sad, Serbia.
    PLoS One. 2022;17:e0274674.
    PubMed         Abstract available
    
    
54. CROCKER-BUQUE T, Myles J, Brentnall A, Gabe R, et al
    Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admission.
    PLoS One. 2022;17:e0274158.
    PubMed         Abstract available
    
    
55. LIN R, Hu X, Guo L, Huang J, et al
    The health benefit of physical exercise on COVID-19 pandemic: Evidence from mainland China.
    PLoS One. 2022;17:e0275425.
    PubMed         Abstract available
    
    
56. TANIS CC, Nauta FH, Boersma MJ, Van der Steenhoven MV, et al
    Practical behavioural solutions to COVID-19: Changing the role of behavioural science in crises.
    PLoS One. 2022;17:e0272994.
    PubMed         Abstract available
    
    
57. BHATIA R, Sledge I, Baral S
    Missing science: A scoping study of COVID-19 epidemiological data in the United States.
    PLoS One. 2022;17:e0248793.
    PubMed         Abstract available
    
    
58. GOHDA T, Murakoshi M, Suzuki Y, Hiki M, et al
    Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients.
    PLoS One. 2022;17:e0275745.
    PubMed         Abstract available
    
    
59. SALMON DA, Schuh HB, Sargent RH, Konja A, et al
    Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population.
    PLoS One. 2022;17:e0274443.
    PubMed         Abstract available
    
    
60. HEATON-SHRESTHA C, Torrens-Burton A, Leggat F, Islam I, et al
    Co-designing personalised self-management support for people living with long Covid: The LISTEN protocol.
    PLoS One. 2022;17:e0274469.
    PubMed         Abstract available
    
    
61. LAJOIE AS, Holm RH, Anderson LB, Ness HD, et al
    Nationwide public perceptions regarding the acceptance of using wastewater for community health monitoring in the United States.
    PLoS One. 2022;17:e0275075.
    PubMed         Abstract available
    
    
62. THORNTON GM, Fleck BA, Dandnayak D, Kroeker E, et al
    The impact of heating, ventilation and air conditioning (HVAC) design features on the transmission of viruses, including the 2019 novel coronavirus (COVID-19): A systematic review of humidity.
    PLoS One. 2022;17:e0275654.
    PubMed         Abstract available
    
    
63. CASSIMON D, Fadare O, Mavrotas G
    The combined effect of institutional quality and capital flows on food and nutrition security and undernourishment in Sub-Saharan Africa.
    PLoS One. 2022;17:e0275345.
    PubMed         Abstract available
    
    
64. DJURIC O, Larosa E, Cassinadri M, Cilloni S, et al
    Surveillance, contact tracing and characteristics of SARS-CoV-2 transmission in educational settings in Northern Italy, September 2020 to April 2021.
    PLoS One. 2022;17:e0275667.
    PubMed         Abstract available
    
    
65. OHASHI Y, Takane Y, Nakajima K
    Impact of the COVID-19 pandemic on changes in temperature-sensitive cardiovascular and respiratory disease mortality in Japan.
    PLoS One. 2022;17:e0275935.
    PubMed         Abstract available
    
    
66. MORRISON FJ, Su M, Turchin A
    COVID-19 outcomes in patients taking cardioprotective medications.
    PLoS One. 2022;17:e0275787.
    PubMed         Abstract available
    
    
67. RIERA-LOPEZ N, Gaetano-Gil A, Martinez-Gomez J, Rodriguez-Rodil N, et al
    The COVID-19 pandemic effect on the prehospital Madrid stroke code metrics and diagnostic accuracy.
    PLoS One. 2022;17:e0275831.
    PubMed         Abstract available
    
    
68. BAEK K, Maharjan S, Akauliya M, Thapa B, et al
    Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model.
    PLoS One. 2022;17:e0275722.
    PubMed         Abstract available
    
    
69. LIU JJ, Mukhopadhyay A, Yeung CW
    Psychological and behavioral responses to the declaration of COVID-19 as a pandemic: A comparative study of Hong Kong, Singapore, and the U.S.
    PLoS One. 2022;17:e0275854.
    PubMed         Abstract available
    
    
70. ARANDA J, Oriol I, Feria L, Abelenda G, et al
    Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter study.
    PLoS One. 2022;17:e0275615.
    PubMed         Abstract available
    
    
71. SHRAGAI T, Pratt C, Castro Georgi J, Donnelly MAP, et al
    Household characteristics associated with surface contamination of SARS-CoV-2 and frequency of RT-PCR and viral culture positivity-California and Colorado, 2021.
    PLoS One. 2022;17:e0274946.
    PubMed         Abstract available
    
    
72. BACANIN N, Budimirovic N, K V, Strumberger I, et al
    Novel chaotic oppositional fruit fly optimization algorithm for feature selection applied on COVID 19 patients' health prediction.
    PLoS One. 2022;17:e0275727.
    PubMed         Abstract available
    
    
73. MESURADO B, Richaud MC, Vanney CE, Pastorelli C, et al
    Promoting positive emotions and instilling concern for the needs of others during the COVID-19 pandemic.
    PLoS One. 2022;17:e0272922.
    PubMed         Abstract available
    
    
74. DECAMP W, Horvitz B, Garza Mitchell RL, Kowalske MG, et al
    Development of a self-report instrument for measuring online teaching practices and discussion facilitation.
    PLoS One. 2022;17:e0275880.
    PubMed         Abstract available
    
    
75. FILISETTI S, Tortora C, Paruta C, Piazza FI, et al
    The sexuality of couples formed during the pandemic: An exploratory study.
    PLoS One. 2022;17:e0275068.
    PubMed         Abstract available
    
    
76. GHALI H, Ghammem R, Baccouche I, Hamrouni M, et al
    Association between lifestyle choices and mental health among medical students during the COVID-19 pandemic: A cross-sectional study.
    PLoS One. 2022;17:e0274525.
    PubMed         Abstract available
    
    
77. ODUSANYA OO, Adeniran A, Bakare OQ, Odugbemi BA, et al
    Building capacity of primary health care workers and clients on COVID-19: Results from a web-based training.
    PLoS One. 2022;17:e0274750.
    PubMed         Abstract available
    
    
78. LAMB D, Wright L, Scott H, Croak B, et al
    Capturing the experiences of UK healthcare workers during the COVID-19 pandemic: A structural topic modelling analysis of 7,412 free-text survey responses.
    PLoS One. 2022;17:e0275720.
    PubMed         Abstract available
    
    
79. ALIZAD-RAHVAR AR, Sadeghi M
    Effect of asymptomatic transmission and emergence time on multi-strain viral disease severity.
    PLoS One. 2022;17:e0269464.
    PubMed         Abstract available
    
    
80. BUSTAMANTE-UBILLA M, Campos-Troncoso RM, Carvache-Franco O, Carvache-Franco M, et al
    Perception study of state support programs for companies, in Talca, Chile in times of Covid 19.
    PLoS One. 2022;17:e0274051.
    PubMed         Abstract available
    
    
81. ZAVALIS EA, Ioannidis JPA
    A meta-epidemiological assessment of transparency indicators of infectious disease models.
    PLoS One. 2022;17:e0275380.
    PubMed         Abstract available
    
    
82. GEWALT SC, Berger S, Krisam R, Krisam J, et al
    "University students' economic situation during the COVID-19 pandemic: A cross-sectional study in Germany".
    PLoS One. 2022;17:e0275055.
    PubMed         Abstract available
    
    
83. COONEY EB, Walton CJ, Gonzalez S
    Getting DBT online down under: The experience of Australian and New Zealand Dialectical Behaviour Therapy programmes during the Covid-19 pandemic.
    PLoS One. 2022;17:e0275636.
    PubMed         Abstract available
    
    
84. GOLLUST SE, Frenier C, Tait M, Bogucki C, et al
    Television airings of U.S. federal COVID-19 public service announcements in 2020 were associated with market-level political orientation, not COVID-19 rates.
    PLoS One. 2022;17:e0275595.
    PubMed         Abstract available
    
    
85. KHALIL FO, Taj MB, Ghonaim EM, Abed El-Sattar S, et al
    Hydrothermal assisted biogenic synthesis of silver nanoparticles: A potential study on virulent candida isolates from COVID-19 patients.
    PLoS One. 2022;17:e0269864.
    PubMed         Abstract available
    
    
86. TRIVEDI A, Robinson C, Blazes M, Ortiz A, et al
    Deep learning models for COVID-19 chest x-ray classification: Preventing shortcut learning using feature disentanglement.
    PLoS One. 2022;17:e0274098.
    PubMed         Abstract available
    
    
87. VAZQUEZ-AGRA N, Marques-Afonso AT, Cruces-Sande A, Novo-Veleiro I, et al
    Assessment of oxidative stress markers in elderly patients with SARS-CoV-2 infection and potential prognostic implications in the medium and long term.
    PLoS One. 2022;17:e0268871.
    PubMed         Abstract available
    
    
88. TUFA A, Gebremariam TH, Manyazewal T, Asrat Y, et al
    Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19.
    PLoS One. 2022;17:e0275391.
    PubMed         Abstract available
    
    
89. SCHWAB C, Frenzel AC, Daumiller M, Dresel M, et al
    "I'm tired of black boxes!": A systematic comparison of faculty well-being and need satisfaction before and during the COVID-19 crisis.
    PLoS One. 2022;17:e0272738.
    PubMed         Abstract available
    
    
90. NAKHAEE H, Zangiabadian M, Bayati R, Rahmanian M, et al
    The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0267423.
    PubMed         Abstract available
    
    
91. SHAHRIN L, Parvin I, Sarmin M, Abbassi NA, et al
    In-person training on COVID-19 case management and infection prevention and control: Evaluation of healthcare professionals in Bangladesh.
    PLoS One. 2022;17:e0273809.
    PubMed         Abstract available
    
    
92. HAIDER SI, Ahmed F, Pasha H, Pasha H, et al
    Life satisfaction, resilience and coping mechanisms among medical students during COVID-19.
    PLoS One. 2022;17:e0275319.
    PubMed         Abstract available
    
    
93. BLONDER R, Feldman-Maggor Y, Rap S
    What can be learned from lecturers' knowledge and self-efficacy for online teaching during the Covid-19 pandemic to promote online teaching in higher education.
    PLoS One. 2022;17:e0275459.
    PubMed         Abstract available
    
    
94. BAZZI L, Brouwer S, Planelles Almeida M, Foucart A, et al
    Would you respect a norm if it sounds foreign? Foreign-accented speech affects decision-making processes.
    PLoS One. 2022;17:e0274727.
    PubMed         Abstract available
    
    
95. JESSEN R, Nielsen L, Larsen NB, Cohen AS, et al
    A RT-qPCR system using a degenerate probe for specific identification and differentiation of SARS-CoV-2 Omicron (B.1.1.529) variants of concern.
    PLoS One. 2022;17:e0274889.
    PubMed         Abstract available
    
    
96. GUARDIANI M, Frank P, Kostic A, Edenhofer G, et al
    Causal, Bayesian, & non-parametric modeling of the SARS-CoV-2 viral load distribution vs. patient's age.
    PLoS One. 2022;17:e0275011.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

97. KEUSCH GT, Amuasi JH, Anderson DE, Daszak P, et al
    Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses.
    Proc Natl Acad Sci U S A. 2022;119:e2202871119.
    PubMed         Abstract available
    
    
98. ROSU ME, Lexmond P, Bestebroer TM, Hauser BM, et al
    Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B/Victoria and B/Yamagata lineages.
    Proc Natl Acad Sci U S A. 2022;119:e2211616119.
    PubMed         Abstract available
    
    

    
    Vaccine

99. VOGELSANG EM, Polonijo AN
    Scarier than the flu shot? : The social determinants of shingles and influenza vaccinations among U.S. older adults.
    Vaccine. 2022 Oct 8. pii: S0264-410X(22)01183.
    PubMed         Abstract available
    
    
100. CHEN JY, Hsieh SM, Hwang SJ, Liu CS, et al
     Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study.
     Vaccine. 2022 Oct 7. pii: S0264-410X(22)01200.
     PubMed         Abstract available
     
     
101. MARLOWE E, Pranikoff S, Borsheim B, Salafian K, et al
     Pilot study to determine effect of an altruism intervention focusing on herd immunity to enhance influenza vaccination rates.
     Vaccine. 2022 Oct 6. pii: S0264-410X(22)01194.
     PubMed         Abstract available
     
     
102. PAGUIO JA, Ojikutu BO, Alfonso PG, Yao JS, et al
     Association of culturally competent care with influenza vaccination coverage in the United States.
     Vaccine. 2022 Oct 5. pii: S0264-410X(22)01065.
     PubMed         Abstract available
     
     
103. CHUGHTAI AA, Mohammed S, Al Ariqi L, McCarron M, et al
     Development of a road map to scale up the uptake and utilization of influenza vaccine in 22 countries of Eastern Mediterranean Region.
     Vaccine. 2022 Oct 5. pii: S0264-410X(22)01159.
     PubMed         Abstract available
     
     
104. LIU B, Gidding H, Stepien S, Cretikos M, et al
     Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection.
     Vaccine. 2022 Sep 21. pii: S0264-410X(22)01126.
     PubMed         Abstract available
     
     
105. HABERSAAT KB, Narayan S, Malue Nielsen S, Scherzer M, et al
     How health workers can make a difference in the public COVID-19 vaccination response.
     Vaccine. 2022 Sep 6. pii: S0264-410X(22)01081.
     PubMed        
     
     
106. FRANKENTHAL D, Zatlawi M, Karni-Efrati Z, Keinan-Boker L, et al
     COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.
     Vaccine. 2022 Sep 14. pii: S0264-410X(22)01078.
     PubMed         Abstract available
     
     
107. JACOBSON M, Chang TY, Shah M, Pramanik R, et al
     Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial.
     Vaccine. 2022 Aug 30. pii: S0264-410X(22)01050.
     PubMed         Abstract available
     
     
108. CEANNT R, Vallieres F, Burns H, Murphy J, et al
     Covid-19 vaccine hesitancy and resistance amongst parents of children under 18 years of age in Ireland.
     Vaccine. 2022 Sep 7. pii: S0264-410X(22)01082.
     PubMed         Abstract available
     
     
109. CREVECOEUR J, Hens N, Neyens T, Lariviere Y, et al
     Change in COVID19 outbreak pattern following vaccination in long-term care facilities in Flanders, Belgium.
     Vaccine. 2022 Sep 14. pii: S0264-410X(22)01124.
     PubMed         Abstract available
     
     
110. MONFARED IG
     The connection between COVID-19 vaccine abundance, vaccination coverage, and public trust in government across the globe.
     Vaccine. 2022 Sep 12. pii: S0264-410X(22)01107.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: